Clinical significance of PCSK9 and soluble P-selectin in predicting major adverse cardiovascular events

Researchers have studied the association of proprotein convertase subtilisin/kexin type 9 (PCSK9) with soluble P-selectin (sP-selectin) and their values in predicting major adverse cardiovascular events (MACE) at one-year follow-up in patients with acute coronary syndrome (ACS) receiving dual antiplatelet therapy after primary percutaneous coronary intervention (PCI).

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart